Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03457480 · ClinicalTrials.gov registry record · NA

Text Messages in Preventing Tobacco Use in Young Adults

A NA study of Healthy Subject, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
781
Enrollment target
1
Study location

NCT03457480: Completed NA study of Healthy Subject, sponsored by M.D. Anderson Cancer Center.

NCT03457480 is a NA study of Healthy Subject that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 781 participants, above the 199-participant average among 16 other Healthy Subject trials with a reported enrollment target (292% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03457480, a NA study of Healthy Subject, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
781 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well text messages work in preventing tobacco use in young adults. Text messaging may help to teach young adults about the risks of tobacco products.

Primary Outcome

Participants will take baseline knowledge and risk perceptions about the use of conventional and new and emerging tobacco products among a subset of community college students from the two participating Houston Community College (HCC) campuses (Central and Coleman campuses) Knowledge about whether products contain nicotine scale Yes or No (0-1) A higher score indicates higher knowledge Risk perception for using tobacco products scale from( 1-5) A higher score indicates a higher perception of ris

Conditions Studied

Interventions

  • OTHER Survey Administration
  • BEHAVIORAL Focus Group
  • OTHER Informational Intervention
  • OTHER Computer-Assisted Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 781 participants
Start Date 2013-09-20
Est. Completion 2021-01-29
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT03457480 record still lists

NCT03457480 is an interventional study that assigns participants to a tested intervention. The registered 781 participants enrollment target is mid-sized for trials with a published cap, above the 199-participant average among 16 other Healthy Subject trials with a reported enrollment target (292% higher).

The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT03457480 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03457480 about?

NCT03457480 is a clinical study titled "Text Messages in Preventing Tobacco Use in Young Adults". This trial studies how well text messages work in preventing tobacco use in young adults. Text messaging may help to teach young adults about the risks of tobacco products.

What is the current status of trial NCT03457480?

This trial is currently completed. It is a NA study. The enrollment target is 781 participants. The study started on 2013-09-20. Estimated completion is 2021-01-29.

What conditions does trial NCT03457480 study?

This clinical trial studies the following conditions: Healthy Subject.

What interventions are being tested in trial NCT03457480?

The interventions under investigation include: Survey Administration (OTHER), Focus Group (BEHAVIORAL), Informational Intervention (OTHER), Computer-Assisted Intervention (OTHER).

Who is sponsoring clinical trial NCT03457480?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03457480 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03457480's enrollment target sits among peer trials

781 2nd of 16 the highest of 16 other Healthy Subject trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03457480, the US trial registry maintained by the National Library of Medicine. NCT03457480 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.